ライフサイエンスコーパス: future studies

1 Future studies are needed to address whether similar mechanis

2 Future studies are needed to elucidate the provenance and put

3 Future studies are required to specify the implications of ou

4 Future studies can explore the identity of these genetic fact

5 Future studies in patients are required to assess the potenti

6 Future studies might elucidate how brain diseases change this

7 Future studies need to explore whether DNA methylation altera

8 Future studies of these loci may aid in identifying new targe

9 Future studies promise even more progress, with the hope that

10 Future studies should assess whether therapies to ameliorate

11 Future studies should attempt to replicate these results in o

12 Future studies should evaluate inter-rater reliability of the

13 Future studies should examine the minimum treatment intensity

14 Future studies should explore risk factors for increased AL i

15 Future studies should focus on better defining the role of MA

16 Future studies should focus on understanding the determinants

17 Future studies should measure multiple biomarkers in each can

18 Future studies that focus on mechanisms, resiliency, and vuln

19 Future studies will explore methods to reduce kidney activity

20 ucose homeostasis as efficiently as human ligands, although future studies are needed to define their potential physiolog

21 Some limitations were identified and future studies using a similar approach should aim to overcom

22 l for MRV in B6 mice, providing the foundation for detailed future studies on MRV with the availability of innumerable mu

23 These findings encourage future studies to examine the conditions longitudinally and i

24 distinct miRNA expression of MNs, which is likely to enrich future studies of MN disease.

25 powerful experimental strategy with broad applicability for future studies of disorders with complex genetic etiologies.

26 rmined 1,200 mg to be the recommended single-agent dose for future studies in FL and DLBCL, with 800 mg being sufficient

27 with a chemotherapeutic agent and provides a foundation for future studies in this difficult-to-treat patient population.

28 Our results provide a framework for future studies to understand better the regulation of channel

29 ession and metastasis, these results lay the groundwork for future studies assessing the therapeutic potential of targeti

30 Together, the results of this study lay the groundwork for future studies to explore the role of DNA replication in immu

31 specific upregulated genes, which can serve as markers for future studies in healthy and diseased states.

32 onto other substrates makes them an attractive material for future studies in spatial heterogeneity of electrocatalytic s

33 develop in the HPT-JT syndrome, provide in vivo models for future studies of these tumours.

34 fluence to neurological disorders and point to the need for future studies to better define specific mechanisms of action

35 combination, these results raise several opportunities for future studies of the pathogenesis of thyroid cancer.

36 Recommendations for future studies in this and similar settings include testing t

37 These data provide an invaluable resource for future studies of function and biological significance of m5C

38 ze the findings into a provisional framework that can guide future studies.

39 treatment of patients awaiting LT which may be assessed in future studies.

40 ceably impacts UHI intensity, which should be considered in future studies on air pollution and urban climates.

41 e with MSI < 0.50 and we would advocate full LV coverage in future studies.

42 l patients and will allow the comparison of outcome data in future studies.

43 in Hispanics need to be confirmed and further explained in future studies using different measures of SEP.

44 sk factors and potentially pathogenic alleles identified in future studies.

45 Under-represented populations warrant greater inclusion in future studies.

46 These findings will inform future studies of the recently discovered RV-C, which also ap

47 Ultimately, our work informs future studies about functional chaperone balance and caution

48 ng gaps in our knowledge, and make suggestions on necessary future studies to optimize organ transplantation for older pe

49 We conclude that future studies need to analyze activity-driven adaptations to

50 These findings warrant future studies of intermediary metabolism in patients treated